Comprehensive management of risk factors in peripheral vascular disease. Expert consensus
Copyright © 2021 The Authors. Published by Elsevier España, S.L.U. All rights reserved..
INTRODUCTION: There is currently a degree of divergence among the main clinical practice guidelines on the management of risk factors for peripheral arterial disease (PAD). This project aims to gain understanding of the management of PAD risk factors in clinical practice and to reach a multidisciplinary consensus on the strategies to be followed in order to optimize its identification, treatment, and follow-up.
METHODOLOGY: A multidisciplinary consensus following the Delphi methodology.
RESULTS: Professionals (n = 130) with extensive experience in PAD participated in this consultation. The results suggest that in order to optimize the control of risk factors, efforts should be aimed at: (1) promoting the involvement and awareness of all specialists in the identification of and screening for the disease; (2) guaranteeing the possibility of evaluating the ankle-brachial index (ABI) in all the medical specialties involved; (3) promoting strategies for patients to quit smoking through the use of drugs, programs, or referrals to specialized units; (4) promoting an appropriate Mediterranean-based diet and the prescription of daily exercise; (5) raising awareness of the importance of ensuring LDL cholesterol values below 70 mg/dL, especially in symptomatic but also in asymptomatic patients (<55 mg/dL following the publication of the ESC/EAS guide); (6) recommending the use of antiplatelet therapy in asymptomatic patients with diabetes mellitus (DM) and/or a pathological ABI; and (7) protocolizing the annual evaluation of ABI in high-risk patients.
CONCLUSION: This document presents the 22 agreed-upon strategies which are intended to help professionals optimize multidisciplinary management of PAD risk factors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:222 |
|---|---|
| Enthalten in: |
Revista clinica espanola - 222(2022), 2 vom: 30. Feb., Seite 82-90 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Clinical practice |
|---|
| Anmerkungen: |
Date Completed 11.03.2022 Date Revised 11.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.rceng.2020.11.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327643404 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327643404 | ||
| 003 | DE-627 | ||
| 005 | 20231225201236.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.rceng.2020.11.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1092.xml |
| 035 | |a (DE-627)NLM327643404 | ||
| 035 | |a (NLM)34217671 | ||
| 035 | |a (PII)S2254-8874(21)00110-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Barrios, V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comprehensive management of risk factors in peripheral vascular disease. Expert consensus |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2022 | ||
| 500 | |a Date Revised 11.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 The Authors. Published by Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a INTRODUCTION: There is currently a degree of divergence among the main clinical practice guidelines on the management of risk factors for peripheral arterial disease (PAD). This project aims to gain understanding of the management of PAD risk factors in clinical practice and to reach a multidisciplinary consensus on the strategies to be followed in order to optimize its identification, treatment, and follow-up | ||
| 520 | |a METHODOLOGY: A multidisciplinary consensus following the Delphi methodology | ||
| 520 | |a RESULTS: Professionals (n = 130) with extensive experience in PAD participated in this consultation. The results suggest that in order to optimize the control of risk factors, efforts should be aimed at: (1) promoting the involvement and awareness of all specialists in the identification of and screening for the disease; (2) guaranteeing the possibility of evaluating the ankle-brachial index (ABI) in all the medical specialties involved; (3) promoting strategies for patients to quit smoking through the use of drugs, programs, or referrals to specialized units; (4) promoting an appropriate Mediterranean-based diet and the prescription of daily exercise; (5) raising awareness of the importance of ensuring LDL cholesterol values below 70 mg/dL, especially in symptomatic but also in asymptomatic patients (<55 mg/dL following the publication of the ESC/EAS guide); (6) recommending the use of antiplatelet therapy in asymptomatic patients with diabetes mellitus (DM) and/or a pathological ABI; and (7) protocolizing the annual evaluation of ABI in high-risk patients | ||
| 520 | |a CONCLUSION: This document presents the 22 agreed-upon strategies which are intended to help professionals optimize multidisciplinary management of PAD risk factors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Clinical practice | |
| 650 | 4 | |a Consenso | |
| 650 | 4 | |a Consensus | |
| 650 | 4 | |a Delphi | |
| 650 | 4 | |a Enfermedad arterial periférica | |
| 650 | 4 | |a Factores de riesgo | |
| 650 | 4 | |a Multidisciplinar | |
| 650 | 4 | |a Multidisciplinary | |
| 650 | 4 | |a Peripheral arterial disease | |
| 650 | 4 | |a Práctica clínica | |
| 650 | 4 | |a Risk factors | |
| 700 | 1 | |a Beato, P |e verfasserin |4 aut | |
| 700 | 1 | |a Brotons, C |e verfasserin |4 aut | |
| 700 | 1 | |a Campuzano, R |e verfasserin |4 aut | |
| 700 | 1 | |a Merino-Torres, J F |e verfasserin |4 aut | |
| 700 | 1 | |a Mostaza, J M |e verfasserin |4 aut | |
| 700 | 1 | |a Plana, N |e verfasserin |4 aut | |
| 700 | 1 | |a Rubio, J A |e verfasserin |4 aut | |
| 700 | 1 | |a Comellas, M |e verfasserin |4 aut | |
| 700 | 0 | |a CREVASP working group |e verfasserin |4 aut | |
| 700 | 1 | |a Aicart Bort, Mª Dolores |e investigator |4 oth | |
| 700 | 1 | |a Almagro Múgica, Fátima |e investigator |4 oth | |
| 700 | 1 | |a Arrarte Esteban, Vicente Ignacio |e investigator |4 oth | |
| 700 | 1 | |a Ayala Vigueras, Isabel |e investigator |4 oth | |
| 700 | 1 | |a Barquilla García, Alfonso |e investigator |4 oth | |
| 700 | 1 | |a Bellido Castañeda, Virginia |e investigator |4 oth | |
| 700 | 1 | |a Berenguel Senén, Alejandro |e investigator |4 oth | |
| 700 | 1 | |a Blanco Echevarría, Agustín |e investigator |4 oth | |
| 700 | 1 | |a Botana López, Manuel Antonio |e investigator |4 oth | |
| 700 | 1 | |a Brea Hernando, Ángel |e investigator |4 oth | |
| 700 | 1 | |a Brito Banfiel, Miguel |e investigator |4 oth | |
| 700 | 1 | |a Calsina Juscafresa, Laura |e investigator |4 oth | |
| 700 | 1 | |a Cánovas Molina, María Gloria |e investigator |4 oth | |
| 700 | 1 | |a Carbayo Herencia, Julio Antonio |e investigator |4 oth | |
| 700 | 1 | |a Carrasco Carrasco, Eduardo |e investigator |4 oth | |
| 700 | 1 | |a Carro, Amelia |e investigator |4 oth | |
| 700 | 1 | |a Casañas Martínez, Marta |e investigator |4 oth | |
| 700 | 1 | |a Castilla-Guerra, Luis |e investigator |4 oth | |
| 700 | 1 | |a Cepeda Rodrigo, José María |e investigator |4 oth | |
| 700 | 1 | |a Cinza-Sanjurjo, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Clarà, Albert |e investigator |4 oth | |
| 700 | 1 | |a Comas Samper, José Manuel |e investigator |4 oth | |
| 700 | 1 | |a Cordero, Alberto |e investigator |4 oth | |
| 700 | 1 | |a Cosin Sales, Juan |e investigator |4 oth | |
| 700 | 1 | |a de Juan Bagudá, Javier |e investigator |4 oth | |
| 700 | 1 | |a de la Fuente, Natalia |e investigator |4 oth | |
| 700 | 1 | |a Delgado, Elías |e investigator |4 oth | |
| 700 | 1 | |a Doiz Artázcoz, Esther |e investigator |4 oth | |
| 700 | 1 | |a Durán Martínez, María |e investigator |4 oth | |
| 700 | 1 | |a Escalada, Javier |e investigator |4 oth | |
| 700 | 1 | |a Escobar Cervantes, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Escribano Pardo, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Estallo Laliena, Luis |e investigator |4 oth | |
| 700 | 1 | |a Félix Redondo, Francisco Javier |e investigator |4 oth | |
| 700 | 1 | |a Fernández Pardo, Jacinto |e investigator |4 oth | |
| 700 | 1 | |a Rodriguez-Lacin, Jose María Fernández |e investigator |4 oth | |
| 700 | 1 | |a Ferrer García, Juan Carlos |e investigator |4 oth | |
| 700 | 1 | |a Frías Vargas, Manuel |e investigator |4 oth | |
| 700 | 1 | |a Galarza Tapia, Andrés |e investigator |4 oth | |
| 700 | 1 | |a García León, Andrés |e investigator |4 oth | |
| 700 | 1 | |a García Lerín, Aurora |e investigator |4 oth | |
| 700 | 1 | |a García-Martín, Lisardo |e investigator |4 oth | |
| 700 | 1 | |a Gargallo Fernández, Manuel |e investigator |4 oth | |
| 700 | 1 | |a Gil, Inés Gil |e investigator |4 oth | |
| 700 | 1 | |a Girbés Borrás, Juan |e investigator |4 oth | |
| 700 | 1 | |a Guerra Requena, Mercedes |e investigator |4 oth | |
| 700 | 1 | |a Guijarro Herraiz, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Hernández Martínez, Antonio Miguel |e investigator |4 oth | |
| 700 | 1 | |a Hevia, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Ibarretxe Gerediaga, Daiana |e investigator |4 oth | |
| 700 | 1 | |a Iborra Ortega, Elena |e investigator |4 oth | |
| 700 | 1 | |a Jansen Chaparro, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Jarauta Simón, Estíbaliz |e investigator |4 oth | |
| 700 | 1 | |a Jericó Alba, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Jiménez Muñoz, Beatriz |e investigator |4 oth | |
| 700 | 1 | |a Lahoz, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Leiva Hernando, Luis |e investigator |4 oth | |
| 700 | 1 | |a León Mazorra, Magdalena |e investigator |4 oth | |
| 700 | 1 | |a López Valverde, María Eugenia |e investigator |4 oth | |
| 700 | 1 | |a Lorente Calvo, Rosario |e investigator |4 oth | |
| 700 | 1 | |a Martín Cañuelo, Jorge Jesús |e investigator |4 oth | |
| 700 | 1 | |a Martínez Hervas, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Martínez López, María Ángeles |e investigator |4 oth | |
| 700 | 1 | |a Masmiquel, Luis |e investigator |4 oth | |
| 700 | 1 | |a Matía Cubillo, Ángel Carlos |e investigator |4 oth | |
| 700 | 1 | |a Medina Falcón, Agustín |e investigator |4 oth | |
| 700 | 1 | |a Merino Lanza, Esther |e investigator |4 oth | |
| 700 | 1 | |a Morales-Pérez, Francisco M |e investigator |4 oth | |
| 700 | 1 | |a Morata Barrado, Pilar Caridad |e investigator |4 oth | |
| 700 | 1 | |a Moreno-Pérez, Óscar |e investigator |4 oth | |
| 700 | 1 | |a Morillas Bueno, Miren |e investigator |4 oth | |
| 700 | 1 | |a Mosquera Lozano, Jose Daniel |e investigator |4 oth | |
| 700 | 1 | |a Muñiz Grijalvo, Ovidio |e investigator |4 oth | |
| 700 | 1 | |a Muñoz Rivas, Núria |e investigator |4 oth | |
| 700 | 1 | |a Navas de Solís, María Soledad |e investigator |4 oth | |
| 700 | 1 | |a Obaya Rebollar, Juan Carlos |e investigator |4 oth | |
| 700 | 1 | |a Ortega, Emilio |e investigator |4 oth | |
| 700 | 1 | |a Pallarés-Carratalá, Vicente |e investigator |4 oth | |
| 700 | 1 | |a Párraga Martínez, Ignacio |e investigator |4 oth | |
| 700 | 1 | |a Pascual Fuster, Vicente |e investigator |4 oth | |
| 700 | 1 | |a Peinado Adiego, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Pereira López, Eva María |e investigator |4 oth | |
| 700 | 1 | |a Pérez Lázaro, M Antonia |e investigator |4 oth | |
| 700 | 1 | |a Pérez Pérez, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Pinés Corrales, Pedro J |e investigator |4 oth | |
| 700 | 1 | |a Polo García, Jose |e investigator |4 oth | |
| 700 | 1 | |a Prieto Díaz, Miguel Ángel |e investigator |4 oth | |
| 700 | 1 | |a Quindimil Vázquez, José Antonio |e investigator |4 oth | |
| 700 | 1 | |a Rama Martínez, Teresa |e investigator |4 oth | |
| 700 | 1 | |a Reyes García, Rebeca |e investigator |4 oth | |
| 700 | 1 | |a Ripoll Vera, Tomás |e investigator |4 oth | |
| 700 | 1 | |a Rodilla Sala, Enrique |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez Piñero, Manuel |e investigator |4 oth | |
| 700 | 1 | |a de Buruaga, Víctor Rodríguez Sáenz |e investigator |4 oth | |
| 700 | 1 | |a Ruiz García, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Ruiz Ortiz, Martín |e investigator |4 oth | |
| 700 | 1 | |a Ruiz Palomar, José Manuel |e investigator |4 oth | |
| 700 | 1 | |a Saltijeral Cerezo, Adriana |e investigator |4 oth | |
| 700 | 1 | |a Álvarez, Julio Sánchez |e investigator |4 oth | |
| 700 | 1 | |a Ortiga, Ruth Sánchez |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Revista clinica espanola |d 2013 |g 222(2022), 2 vom: 30. Feb., Seite 82-90 |w (DE-627)NLM21591063X |x 2254-8874 |7 nnns |
| 773 | 1 | 8 | |g volume:222 |g year:2022 |g number:2 |g day:30 |g month:02 |g pages:82-90 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rceng.2020.11.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 222 |j 2022 |e 2 |b 30 |c 02 |h 82-90 | ||